
Evogene Ltd. EVGN
€ 0.64
-0.31%
Geschäftsbericht 2025
hinzugefügt 25.04.2026
Evogene Ltd. Betriebszyklus 2011-2026 | EVGN
Betriebszyklus Jährlich Evogene Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 30 | 98.8 | 41.9 | 39.7 | 33 | 36.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 98.8 | 30 | 46.7 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
3.11 K | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
1.94 K | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
237 | $ 16.89 | -2.37 % | $ 789 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Compugen Ltd.
CGEN
|
60.8 | $ 2.85 | -5.94 % | $ 266 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Coherus BioSciences
CHRS
|
656 | $ 1.58 | -3.37 % | $ 185 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 7.46 | -4.73 % | $ 204 M | ||
|
Eton Pharmaceuticals
ETON
|
189 | $ 29.73 | -0.77 % | $ 800 M | ||
|
Exelixis
EXEL
|
140 | $ 50.09 | -1.98 % | $ 13.6 B | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Fortress Biotech
FBIO
|
325 | $ 2.47 | 7.39 % | $ 68.9 M | ||
|
Fennec Pharmaceuticals
FENC
|
148 | $ 9.51 | 2.92 % | $ 272 M | ||
|
AbCellera Biologics
ABCL
|
173 | $ 4.03 | -8.52 % | $ 1.2 B | ||
|
Autolus Therapeutics plc
AUTL
|
129 | $ 1.57 | -1.26 % | $ 418 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Gilead Sciences
GILD
|
160 | $ 129.56 | -1.9 % | $ 161 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 7.67 | -1.6 % | $ 5.21 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
291 | $ 21.66 | 0.42 % | $ 2.76 B |